Unknown

Dataset Information

0

Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.


ABSTRACT: Dolutegravir (DTG) is a preferred drug for initial treatment of human immunodeficiency virus type 1 infection. We present next-generation sequencing analysis of integrase genotypes during a period of virologic failure in a treatment-naive man who initiated tenofovir disoproxil fumarate/emtricitabine plus DTG.

SUBMITTER: Fulcher JA 

PROVIDER: S-EPMC6093998 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9326666 | biostudies-literature
| S-EPMC8765298 | biostudies-literature
| S-EPMC9792149 | biostudies-literature
| S-EPMC7433307 | biostudies-literature
| S-EPMC10393879 | biostudies-literature
| S-EPMC7205217 | biostudies-literature
| S-EPMC7183126 | biostudies-literature
| S-EPMC3867623 | biostudies-literature
| S-EPMC3797783 | biostudies-literature
| S-EPMC7662175 | biostudies-literature